Found vs MedVi: Affordable biology-first care or simple semaglutide access
Found vs MedVi is a comparison between two telehealth weight loss options with distinct approaches. Early verdict: Found emphasizes a biology-first, personalized medically supervised program that accepts most insurance and starts as low as $39, while MedVi focuses on straightforward access to compounded semaglutide with a promotional first month at $179 and no clinic visits required.
Start Found’s biology-first program
How they differ: program focus and medication options
Found builds personalized weight loss programs around metabolic biology, targeting hormones, blood sugar, sleep, and behavior, and lists tirzepatide and compounded semaglutide among medication options. MedVi emphasizes clinically dosed compounded semaglutide only, with no clinic visits and 24/7 certified medical support.
Pricing and insurance: low starting price versus promo model
Found advertises getting started for as low as $39 and highlights that most insurance is now accepted, including handling insurance paperwork and a Medicare GLP-1 Bridge Program that may help eligible Part D members get brand-name GLP-1s for as little as $50/month subject to program terms. MedVi offers a winter promotional first month at $179 with fast, free shipping, but the ongoing standalone month increases to $299 and a three-month plan is $649 (about $216/month). MedVi does not bill insurance and operates on a cash-pay model, though branded options may be eligible for reimbursement by insurance in some cases.
See MedVi’s promotional semaglutide offer
Pricing qualifiers to note
Found’s marketing includes multiple price points such as starting at $39 and membership tiers starting at $49/month when billed annually, plus statements about advertised pricing with 12 month commitments for branded GLP-1s and non-GLP-1s. MedVi’s $179 figure is a first-month promotion and MedVi explicitly warns the price increases afterward to $299 for a standalone month.
Care model and convenience: personalized medical evaluation versus simple online path
Found conducts a thorough medical evaluation and builds a personalized program designed to address whole-body factors that drive weight gain. MedVi offers a simple online intake and no in-person clinic visits, with an online clinician review that may result in a prescription and shipping to your door. MedVi highlights 24/7 support from certified medical professionals. Both platforms state that prescriptions are subject to clinician review and eligibility.
Explore Found’s personalized evaluation
Medication sourcing and regulatory notes
Both providers offer compounded GLP-1 medications and include regulatory disclaimers that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Found mentions both compounded semaglutide and tirzepatide and also references brand-name GLP-1s where insurance may apply. MedVi focuses on compounded semaglutide and notes its compounded medications are produced in FDA-regulated facilities while remaining not FDA-approved.
Support, program length, and reported outcomes
MedVi markets 24/7 certified medical support and reports patient-reported outcomes such as typical 1 to 2 lb per week weight loss after 4 weeks in some cases, while also noting results vary and depend on adherence. Found emphasizes a holistic program aimed at hormones, metabolism, and lifestyle and claims patients can begin seeing and feeling results as soon as month 1, while also noting results vary by individual.
| Criteria | Found | MedVi |
|---|---|---|
| Primary focus | Biology-first personalized program | Compounded semaglutide access with simple online process |
| Starting price | Get started for as low as $39 | Promotional first month $179; $299 standalone month |
| Insurance | Most insurance now accepted; handles paperwork | Does not bill insurance; cash-pay model |
| Medications available | Tirzepatide, compounded semaglutide, branded options via insurance | Clinically dosed compounded semaglutide only |
| Care model | Personalized medical evaluation and supervised program | Simple online intake, no clinic visits, 24/7 support |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
Who each provider is best for
Found is presented as best for people who want weight loss built around their biology, with insurance handling and multiple medication pathways including tirzepatide and brand-name options when eligible. MedVi is presented as best for patients who want the simplest path to compounded semaglutide therapy with a promotional first month and no clinic visits required.
Compare Found plans and insurance options
Final thoughts on Found vs MedVi
Use the primary keyword Found vs MedVi to remember the core distinction: Found emphasizes a biology-first, personalized program with insurance acceptance and multiple medication options starting as low as $39, while MedVi emphasizes direct, no-clinic compounded semaglutide access with a promotional first month at $179 but higher ongoing prices. Both note that compounded GLP-1s are not FDA-approved and that prescriptions are subject to clinician review.
Choose Found if you want a personalized medically supervised program that targets hormones, metabolism, and lifestyle and you value insurance handling and multiple medication options.
Choose MedVi if you want the simplest online path to clinically dosed compounded semaglutide with a promotional first month and no in-person clinic visits.